A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.
Market Scope
Trusted Global Partner of Industry and Medical Professionals for Ophthalmic Market Research, Primary Research, Independent Perspective, & Objective Analysis
Choose Your Experience
Over 500 Clients, Large & Small from Around the World, Trust Market Scope Data & Analysis
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 378
Comprehensive Pages
- 35
Competitors Profiled
- 11
IOL Categories Forecasted
- 8
Geographic and Economic Breakouts
2025 IOL Market Report: Global Analysis for 2024 to 2030, March, 2025
The “2025 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success.
This report describes and forecasts performance by region for 12 categories of IOLs: commodity monofocal, enhanced monofocal, intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, post-op adjustable, and phakic IOLs. Additionally, 35 companies are profiled, with discussion of their products, strategic market position, background, and outlook.
Latest Industry News & Trends
4/21/2025
ChinaIndiaMeetingNewsletter
Combined APAO-AIOS Meeting Draws 12,500 to New Convention Center in India
Around 12,500 delegates attended the 2025 joint meeting of the Asia-Pacific Academy of Ophthalmology and All-India Ophthalmolog-ical Society, with more than 1,300 international visitors. The confer...
4/21/2025
AIChinaDiagnosticIndiaMeetingNewsletter
Asia-Pacific Leads Push to Get AI from the Bench to the Bedside
Bridging the gap between artificial intelligence development and deployment in ophthalmology was the main theme of a Thursday morning session on AI innovation at the 2025 APAO-AIOS meeting. Paisan ...
4/21/2025
AcquisitionsDealsFundingNewsletter
Ophthalmic Venture Capital Funding Hits a Seven-Quarter Peak
Venture capital investments accounted for over half of all ophthalmic deals in Q1-2025, with financing rounds totaling $515.7 million—the highest quarter since Q3-2023, when these transactions reac...
4/21/2025
CataractIOLNewsletterPremium
Better IOLs, Push from Surgeons Will Drive Healthy Premium Growth
Cataract surgeons’ focus on premium IOLs will increase over the next five years due to improved technology and continued declines in reimbursement for monofocal cataract surgery. Premium IOLs, incl...
4/21/2025
AcquisitionsCataractFLACSNewsletter
Alcon Agrees to Buy Lensar in Deal Worth up to $430 Million
Alcon announced March 24 that it had entered into a definitive agreement to acquire Lensar, including its Ally femtosecond laser cataract system, its Streamline software, and the Lensar legacy lase...
4/21/2025
CataractIOLNewsletter
Alcon Introduces Clareon PanOptix Pro IOL
Alcon on April 2 introduced its Clareon PanOptix Pro trifocal IOL, a next-generation version of its groundbreaking PanOptix model. The company said the lens had been made available to select US pra...
4/21/2025
Dry EyeNewsletterRegulation
US FDA Again Rejects Aldeyra’s Reproxalap for Dry Eye, Asks for Yet Another Symptom Trial
Aldeyra Therapeutics reported April 3 that the US FDA had once again issued a complete response letter rejecting the company’s new drug application (NDA) for topical reproxalap as a treatment for d...
4/21/2025
NewsletterPresbyopiaRefractive
Orasis Launches Qlosi Presbyopia Drops in US
Orasis Pharmaceuticals announced April 7 that Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% eye drops for the treatment of presbyopia are now available to prescribe in the US. Orasis s...
Provider Surveys & Interviews
Grab a seat at the table and join the thousands of ophthalmologists and optometrists from over 60 countries who are helping shape the next generation of diagnostics, pharmaceuticals, devices, and equipment by sharing your opinion and experience. Make your voice heard!
Choose Your Own Adventure
Participation options include weekly polls, special sponsored surveys, syndicated quarterly surveys, focus groups, and interviews, each with varying levels of honoraria.
Safe, Secure & On Any Device
We follow all industry standards to ensure confidentiality between participants and clients. Start and stop surveys anytime on our free Market Scope+ App or on desktop, each with a personalized dashboard just for you.
Pre-Qualified Invitations
We individually verify all potential participants before each survey or interview, ensuring that only licensed eye care professionals are invited and they are never kicked out or disqualified.
Better Data = Better Decisions
A team of industry experts and analysts review each data point, so you can be confident in the results and trends provided in our reports.
Download the Market Scope+ app to get started!
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.